These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32798995)

  • 1. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.
    Wisneski AD; Jin C; Huang CY; Warren R; Hirose K; Nakakura EK; Corvera CU
    J Surg Res; 2020 Dec; 256():476-485. PubMed ID: 32798995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and Outcomes of Synchronous Resection of Colorectal Metastasis in the Modern Era-Analysis of Targeted Hepatic NSQIP Database.
    Jones TJ; Murphy AE; Tameron A; Hussain LR; Grannan K; Guend H; Dunki-Jacobs EM; Lee DY
    J Surg Res; 2019 Jun; 238():35-40. PubMed ID: 30735964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE Inhibitor Therapy Does Not Influence the Survival Outcomes of Patients with Colorectal Liver Metastases Following Liver Resection.
    Sanyal S; Alabraba E; Ibrahim H; Olaru A; Cameron I; Gomez D
    J Gastrointest Cancer; 2021 Mar; 52(1):106-112. PubMed ID: 31853827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Time to Surgery of Colorectal Liver Metastases on Survival.
    Chen EY; Mayo SC; Sutton T; Kearney MR; Kardosh A; Vaccaro GM; Billingsley KG; Lopez CD
    J Gastrointest Cancer; 2021 Mar; 52(1):169-176. PubMed ID: 32086781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
    Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi-center data analysis using LiverMetSurvey.
    Bonney GK; Coldham C; Adam R; Kaiser G; Barroso E; Capussotti L; Laurent C; Verhoef C; Nuzzo G; Elias D; Lapointe R; Hubert C; Lopez-Ben S; Krawczyk M; Mirza DF;
    J Surg Oncol; 2015 May; 111(6):716-24. PubMed ID: 25864987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in primary and iterative surgery of colorectal liver metastases.
    Tonelli F; Leo F; Nobili S; Mini E; Batignani G
    J Chemother; 2010 Oct; 22(5):358-63. PubMed ID: 21123161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
    Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
    ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
    Zhang Y; Wang Y; Yuan Y; Qiu J; Qiu Y; He W; Zheng Y; Wang Z; Gu Y; Lu Z; Chen G; Ding P; Wu X; Pan Z; Wan D; Li Y; Xu R; Yuan Y; Li B
    World J Surg Oncol; 2020 May; 18(1):98. PubMed ID: 32423450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interval period tumor progression: does delayed hepatectomy detect occult metastases in synchronous colorectal liver metastases?
    Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Mitsuhashi N; Takeuchi D; Iida A; Miyazaki M
    J Gastrointest Surg; 2008 Aug; 12(8):1391-8. PubMed ID: 18491195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of parenchymal preserving surgery on survival and recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; Bell R; White A; Pathak S; Hidalgo E; Lodge P; Prasad R; Toogood G
    ANZ J Surg; 2018 Jan; 88(1-2):66-70. PubMed ID: 27111217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients.
    Viganò L; Capussotti L; Lapointe R; Barroso E; Hubert C; Giuliante F; Ijzermans JN; Mirza DF; Elias D; Adam R
    Ann Surg Oncol; 2014 Apr; 21(4):1276-86. PubMed ID: 24346766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
    Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
    Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the strategy for curative treatment of synchronous colorectal cancer liver metastases.
    Raoux L; Maulat C; Mokrane FZ; Fares N; Suc B; Muscari F
    J Visc Surg; 2020 Aug; 157(4):289-299. PubMed ID: 32089468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.